Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

Clinical trial NCT07485010 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07485010
Sponsor: The University of Queensland
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mycobacterium Abscessus Pulmonary Disease Mycobacterium Abscessus Infection Non-Tuberculous Mycobacterial (NTM) Infections Non-Tuberculous Mycobacteria Pulmonary Disease

Start date: 2027-04-01
Primary completion: 2031-04-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.